The main purpose of this legislation, known as the Agility in Manufacturing Preparedness Act of 2025, is to enhance collaboration between the Biomedical Advanced Research and Development Authority (BARDA) and the Manufacturing USA network of institutes. This collaboration aims to improve the development and deployment of technologies that can respond to public health needs. Key provisions of the Act include amendments to existing law that expand the scope of BARDA's strategic initiatives.